Financial Performance - The company reported unaudited consolidated financial results for the six months ended June 30, 2021, comparing with the same period in 2020[10]. - Revenue for the three months ended June 30, 2021, was SGD 2,800,000, a significant increase from SGD 965,000 in the same period of 2020, representing a growth of 190%[11]. - Gross profit for the six months ended June 30, 2021, was SGD 5,148,000, compared to SGD 3,546,000 in the same period of 2020, reflecting a year-on-year increase of 45%[11]. - The company reported a net loss attributable to owners of the company of SGD 1,111,000 for the three months ended June 30, 2021, compared to a loss of SGD 819,000 in the same period of 2020, indicating a 36% increase in losses[11]. - Total revenue for the group was SGD 6,918,000 for the six months ended June 30, 2021, compared to SGD 4,951,000 in 2020, marking a 39.5% increase[27]. - The group reported a pre-tax loss of SGD 1,546,000 for the six months ended June 30, 2021, compared to a loss of SGD 2,199,000 for the same period in 2020, indicating a 29.7% improvement[35]. - For the six months ended June 30, 2021, the company reported a net loss of SGD 1,563,000, compared to a net loss of SGD 2,227,000 for the same period in 2020, representing a 29.8% improvement[40]. - The basic loss per share for the six months ended June 30, 2021, was (0.31) Singapore cents, an improvement from (0.45) Singapore cents for the same period in 2020[40]. Assets and Liabilities - Total assets as of June 30, 2021, were SGD 16,380,000, down from SGD 19,188,000 as of December 31, 2020, showing a decrease of 14.6%[13]. - The company’s total equity decreased to SGD 4,539,000 as of June 30, 2021, from SGD 6,066,000 as of December 31, 2020, representing a decline of 25.2%[13]. - As of June 30, 2021, trade receivables net amount was SGD 20,000, down from SGD 85,000 as of December 31, 2020, indicating a 76.5% decrease[44]. - The company reported a net amount of refundable deposits of SGD 1,522,000 as of June 30, 2021, slightly up from SGD 1,518,000 as of December 31, 2020[48]. - As of June 30, 2021, the total liabilities amounted to SGD 8,329,000, a slight decrease from SGD 8,362,000 as of December 31, 2020[53]. Cash Flow - Cash and cash equivalents decreased to SGD 3,530,000 as of June 30, 2021, from SGD 4,649,000 at the beginning of the period, a decline of 24%[18]. - Operating cash flow for the six months ended June 30, 2021, was negative at SGD (507,000), compared to positive cash flow of SGD 559,000 in the same period of 2020[18]. - The company reported a net cash outflow from financing activities of SGD 2,206,000 for the six months ended June 30, 2021, compared to SGD 2,003,000 in the same period of 2020, reflecting an increase in cash outflow of 10.1%[18]. Corporate Governance - The board of directors confirmed that the financial information presented is accurate and complete, with no misleading or fraudulent elements[3]. - The board includes executive directors and independent non-executive directors, ensuring compliance with corporate governance standards[6]. - The company has established various committees, including an audit committee and a remuneration committee, to oversee its operations[7]. - The audit committee, consisting of independent non-executive directors, reviewed the unaudited interim results for the six months ending June 30, 2021[109]. - The company has maintained compliance with the corporate governance code, although the roles of Chairman and CEO are held by the same individual[106]. Market and Operational Context - The company acknowledges the potential market volatility and lower liquidity associated with trading on the GEM[2]. - The company aims to provide a transparent overview of its financial performance and business objectives[3]. - Singapore's vaccination rate has reached 70% of the population, and the country is gradually reopening, which is expected to improve revenue and cash flow[62]. - The company plans to continue cost-saving measures to offset the impact of pandemic-related restrictions on its operations in Singapore and Malaysia[63]. - The company will monitor changes in consumer behavior due to prolonged lockdowns and adjust its business strategies accordingly to minimize losses[63]. Shareholder Information - Liu Wan-Zhen holds a beneficial interest in 282 million shares, representing 56.4% of the company's shares as of June 30, 2021[94]. - The major shareholder, Jingxin Rehabilitation Hospital (International) Limited, holds 90.5 million shares, representing 18.1% of the company's shares[99]. - The company has issued 500,000,000 ordinary shares, with a par value of HKD 0.01 per share, and no new shares were issued during the reporting period[57]. - The company did not recommend any interim dividend for the six months ended June 30, 2021, consistent with the previous year[39]. Segment Performance - Revenue for the restaurant business reached SGD 5,494,000 for the six months ended June 30, 2021, compared to SGD 3,632,000 for the same period in 2020, representing a 51.4% increase[27]. - The bakery segment generated revenue of SGD 1,417,000 for the six months ended June 30, 2021, up from SGD 1,309,000 in the previous year, reflecting an 8.3% growth[27]. - The group operates two reportable segments: the restaurant business and the bakery segment, focusing on resource allocation and performance evaluation[31]. Future Outlook - The company anticipates reporting more information and updates in the next quarterly report to safeguard stakeholder interests[64]. - The company plans to use the unutilized net proceeds according to the announcement dated July 2, 2021, with the timeline dependent on future developments[90]. - The company will continue to review the separation of the roles of Chairman and CEO at an appropriate time[106].
聚利宝控股(08527) - 2021 - 中期财报